Follow
Gantt Galloway
Gantt Galloway
Director of Clinical Research, Ria Health
Verified email at riahealth.com
Title
Cited by
Cited by
Year
Psychiatric symptoms in methamphetamine users
JE Zweben, JB Cohen, D Christian, GP Galloway, M Salinardi, D Parent, ...
American Journal on Addictions 13 (2), 181-190, 2004
5902004
A multi‐site comparison of psychosocial approaches for the treatment of methamphetamine dependence
RA Rawson, P Marinelli‐Casey, MD Anglin, A Dickow, Y Frazier, ...
Addiction 99 (6), 708-717, 2004
5042004
Gamma‐hydroxybutyrate: an emerging drug of abuse that causes physical dependence
GP Galloway, SL Frederick, FE Staggers Jr, M Gonzales, SA Stalcup, ...
Addiction 92 (1), 89-96, 1997
3741997
Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers
CE Johanson, KA Frey, LH Lundahl, P Keenan, N Lockhart, J Roll, ...
Psychopharmacology 185, 327-338, 2006
2642006
Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals
R Salo, TE Nordahl, K Possin, M Leamon, DR Gibson, GP Galloway, ...
Psychiatry research 111 (1), 65-74, 2002
2292002
Drug Abuse Sciences Naltrexone Depot Study Group: Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial
HR Kranzler, DR Wesson, L Billot
Alcohol Clin Exp Res 28, 1051-1059, 2004
222*2004
Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis
DT Hartz, SL Frederick-Osborne, GP Galloway
Drug and alcohol dependence 63 (3), 269-276, 2001
1962001
Psychiatric comorbidity in methamphetamine dependence
R Salo, K Flower, A Kielstein, MH Leamon, TE Nordahl, GP Galloway
Psychiatry research 186 (2-3), 356-361, 2011
1812011
Attentional control and brain metabolite levels in methamphetamine abusers
R Salo, TE Nordahl, Y Natsuaki, MH Leamon, GP Galloway, C Waters, ...
Biological psychiatry 61 (11), 1272-1280, 2007
1642007
Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up
S Glasner-Edwards, P Marinelli-Casey, M Hillhouse, A Ang, LJ Mooney, ...
The Journal of nervous and mental disease 197 (4), 225, 2009
1582009
A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence
RF Anton, H Pettinati, A Zweben, HR Kranzler, B Johnson, MJ Bohn, ...
Journal of clinical psychopharmacology 24 (4), 421-428, 2004
1492004
Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study
TE Nordahl, R Salo, Y Natsuaki, GP Galloway, C Waters, CD Moore, ...
Archives of general psychiatry 62 (4), 444-452, 2005
1412005
Abuse potential of dronabinol (Marinol®)
SR Calhoun, GP Galloway, DE Smith
Journal of psychoactive drugs 30 (2), 187-196, 1998
1321998
Drug abstinence and cognitive control in methamphetamine-dependent individuals
R Salo, TE Nordahl, GP Galloway, CD Moore, C Waters, MH Leamon
Journal of substance abuse treatment 37 (3), 292-297, 2009
1292009
Psychopathology in methamphetamine‐dependent adults 3 years after treatment
S GLASNER‐EDWARDS, LJ Mooney, P MARINELLI‐CASEY, ...
Drug and alcohol review 29 (1), 12-20, 2010
1222010
Cognitive control and white matter callosal microstructure in methamphetamine-dependent subjects: a diffusion tensor imaging study
R Salo, TE Nordahl, MH Buonocore, Y Natsuaki, C Waters, CD Moore, ...
Biological psychiatry 65 (2), 122-128, 2009
1212009
Ritanserin in the treatment of alcohol dependence–a multi-center clinical trial
BA Johnson, DR Jasinski, GP Galloway, H Kranzler, R Weinreib, ...
Psychopharmacology 128, 206-215, 1996
1181996
Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study
TE Nordahl, R Salo, K Possin, DR Gibson, N Flynn, M Leamon, ...
Psychiatry Research: Neuroimaging 116 (1-2), 43-52, 2002
1172002
Abuse of flunitrazepam (Rohypnol) and other benzodiazepines in Austin and South Texas
SR Calhoun, DR Wesson, GP Galloway, DE Smith
Journal of Psychoactive Drugs 28 (2), 183-189, 1996
1141996
Sober living houses for alcohol and drug dependence: 18-month outcomes
DL Polcin, RA Korcha, J Bond, G Galloway
Journal of substance abuse treatment 38 (4), 356-365, 2010
1112010
The system can't perform the operation now. Try again later.
Articles 1–20